CDT EQUITY INC
CDT · NASDAQ
更新於 2026-10-13 15:28:33
- 今日最高
- $0.61
- 今日最低
- $0.41
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $0.70
- 昨天收盤價
- $0.66
- 成交量
- 373.02K
- 市值
- $742.18K
- 市盈率（P/E）
- --
- 每股收益（EPS）
- $-5,400.36
昨天價格區間
52週價格區間
公司概況
- 板塊
- 醫療保健
- 行業
- 生命科學工具與服務
- 子行業
- 生物科技
- 總部
- 4581 TAMIAMI TRAIL NORTH, NAPLES, FL, UNITED STATES, 34103
- 國家
- 美國
- 上市日期
- 2022-02-03
- 財年截止
- 十二月
- 流通股數
- 660K
- CIK
- 0001896212
Conduit Pharmaceuticals Inc. (CDT) 是一家臨床階段生物製藥公司，專注於為腫瘤及罕見疾病創造創新療法，針對重大未滿足的醫療需求。利用其專有藥物遞送技術，Conduit 旨在提高現有療法的有效性及安全性，從而改善患者預後並減少不良反應。在經驗豐富的管理團隊及策略合作支持下，公司處於有利地位，可推進其變革性產品管線，並有可能對醫療保健格局產生重大影響。
財務指標
營業收入
2026-06-30
$750.15M
2026-03-31
$696.37M
2025-12-31
$2.71B
2025-09-30
$698.22M
營業支出
2026-06-30
$183.65M
2026-03-31
$180.12M
2025-12-31
$21.15M
2025-09-30
$7.03M
淨利潤
2026-06-30
$68.53M
2026-03-31
$51.02M
2025-12-31
-$21.32M
2025-09-30
-$7.11M
淨利潤率
2026-06-30
9.13%
2026-03-31
7.32%
2025-12-31
-0.78%
2025-09-30
-1.01%
每股收益
2026-06-30
$-8.71
2026-03-31
$-99.99
2025-12-31
$-57,860.32
2025-09-30
$-13.16
息稅折舊攤銷前利潤
2026-06-30
$127.67M
2026-03-31
$108.68M
2025-12-31
-$18.87M
2025-09-30
-$6.18M
有效稅率
2026-06-30
19.56%
2026-03-31
18.7%
2025-12-31
-138.05%
2025-09-30
1.36%
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $750.15M | $696.37M | $2.71B | $698.22M |
| 營業支出 | $183.65M | $180.12M | $21.15M | $7.03M |
| 淨利潤 | $68.53M | $51.02M | -$21.32M | -$7.11M |
| 淨利潤率 | 9.13% | 7.32% | -0.78% | -1.01% |
| 每股收益 | $-8.71 | $-99.99 | $-57,860.32 | $-13.16 |
| 息稅折舊攤銷前利潤 | $127.67M | $108.68M | -$18.87M | -$6.18M |
| 有效稅率 | 19.56% | 18.7% | -138.05% | 1.36% |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。